<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="92540">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02075554</url>
  </required_header>
  <id_info>
    <org_study_id>RGC10-009-001-PL_H_2</org_study_id>
    <nct_id>NCT02075554</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Expandable Spacer in the Treatment of Degenerative Disc Disease Using the Minimally Invasive Transforaminal Lumbar Interbody Fusion Surgical Approach</brief_title>
  <acronym>CALIBER</acronym>
  <official_title>Study of an Expandable Interbody Device for the Lumbar Spine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Globus Medical Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mt. Sinai Medical Center, Miami</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Carolina Neurosurgery &amp; Spine Associates</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Globus Medical Inc</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to evaluate the safety and efficacy of CALIBER
      expandable spacer for the treatment of degenerative disc disease. Radiographic outcomes,
      intra-operative parameters, clinical outcomes, and patient satisfaction will be obtained
      from patients in this 2 year follow-up clinical study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be followed-up at 3weeks, 6 weeks, 3 months, 6 months, 12 and 24 months with
      X-rays and questionnaires to determine their satisfaction, healing, fusion and return to
      work status
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">September 2015</completion_date>
  <primary_completion_date type="Anticipated">July 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Fusion and disc height maintenance</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>X-rays and patient questionnaires to be done/completed</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient Self Assessment</measure>
    <time_frame>Upto 24 mo</time_frame>
    <safety_issue>No</safety_issue>
    <description>Questionnaires on health and healing status will be completed by patients at all follow-up visits</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Degenerative Disc Disease</condition>
  <arm_group>
    <arm_group_label>CALIBER</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>1 or 2 levels of DDD between L2 and S1, treated with transforaminal interbody fusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CALIBER</intervention_name>
    <description>Expandable interbody spacer</description>
    <arm_group_label>CALIBER</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  DDD at 1 or 2 levels between L2 and S1

          -  Between 18 and 80 years of age

          -  Unresponsiveness to documented non-surgical treatment modalities for a minimum of six
             months

          -  Ability to provide a signed Informed Consent

        Exclusion Criteria:

          -  Trauma at level(s) to be fused

          -  Previous documentation of osteopenia, osteoporosis, or osteomalacia to a degree that
             spinal instrumentation would be contraindicated

          -  Immunosuppressive disorder

          -  History of substance abuse

          -  Any known allergy to a metal alloy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dan Cohen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mount Sinai School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>South Florida Spine Institute at Mt Sinai Medical Center</name>
      <address>
        <city>Miami Beach</city>
        <state>Florida</state>
        <zip>33140</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dan Cohen, MD</last_name>
      <phone>305-532-7494</phone>
      <email>dscspine@aol.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Carolina NeuroSurgery and Spine Associates</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dom Coric, MD</last_name>
      <phone>704-376-1605</phone>
      <email>dom.coric@cnsa.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 27, 2014</lastchanged_date>
  <firstreceived_date>February 4, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Spinal Diseases</mesh_term>
    <mesh_term>Intervertebral Disk Degeneration</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
